Organization · Angel Group
Angels Santé
Angels Santé is a Paris-based network of Business Angels focused on investing in innovative startups within the health sector, particularly in Biotech, Medtech, and E-Health.
Overview
What Angels Santé does
What Angels Santé is
Angels Santé is a Paris-based network of Business Angels focused on investing in innovative startups within the health sector, particularly in Biotech, Medtech, and E-Health.
How it participates in the startup ecosystem
The current public profile supports funder capabilities. Each capability below is shown separately so organization identity and role-specific information do not get conflated.
Operational profile
Organization status and context
Organization status describes the entity itself. Funding and program availability appear within the relevant capability profile.
- Operational status
- Active
- Organization type
- Angel Group
- Founded
- Founded in 2008
- Approximate age
- About 18 years
- Structured capabilities
- Funder
- Last reviewed
- March 4, 2026
Official channels
Find Angels Santé elsewhere
Open the official website or a supported primary organization account.
Capability profile
Angels Santé as a funder
Investment thesis
Angels Santé invests in startups within the health sector, specifically in Biotech, Medtech, and E-Health. The organization aims to provide 'smart money' by leveraging the expertise of its investors to support the development of innovative health solutions.
Focus narrative
Angels Santé invests in startups within the health sector, specifically in Biotech, Medtech, and E-Health. The organization aims to provide 'smart money' by leveraging the expertise of its investors to support the development of innovative health solutions.
Focus and fit
- Stages
- Seed · Series A
Availability
- Currently deploying
- Not published
Portfolio and track record
Portfolio context
Notable portfolio companies include: HOCOIA: Offers connected health buses equipped with medical devices for high-quality consultations. Byome Labs: Specializes in microbiome analysis to assist brands in understanding the impact of their products. Steminov: Develops a platform for cell therapy using umbilical cord-derived stem cells. Myfit Solution: Provides a B2B software solution for 3D body digitization. AUSTRAL Dx: Innovates in diagnosing cardiac and pulmonary diseases using airborne ultrasound. Vulgaroo: Simplifies medical reports for better patient understanding. MB Therapeutics: Enables pharmacies to create personalized medications through 3D printing. Sirius NeoSight: Focuses on detecting early-stage cancers and monitoring patient treatment. HuntX Pharma: Develops oral molecules to prevent genetic neurodegenerative diseases. Alga Therapeutics: Produces antibodies from microalgae to combat cancer. Abcely: Innovates in medical technologies for treating mucosal cancers. Odimma Therapeutics: Works on personalized immunotherapy using AI and synthetic DNA technology. Kimialys: Develops a patented chemical coating to enhance diagnostic test reliability. Hephaistos Pharma: Focuses on a new generation of immunostimulants for treating metastatic tumors.
Common questions
What to know about Angels Santé
Upseed classifies Angels Santé under the Angel Group organization type. Its current public profile includes funder capabilities.
Source and update disclosure
Know what this page is based on
Source basis
Public organization and program material, official websites, and structured Upseed records.
Last reviewed
March 4, 2026
Known limits
Capability profiles appear only when a structured public profile also contains decision-useful role evidence. Terms and availability can change.
Upseed is an independent guide. It is not affiliated with or endorsed by the organization described on this page.